Does genetic variation influence response to treatment with vascular endothelial growth factor inhibitors in neovascular age-related macular degeneration?
Center for Experimental Medicine, Queen's University Belfast , Belfast , UK and.
Usha
U
Chakravarthy
Stephanie A
SA
Hagstrom
D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D050506:Mutant Chimeric Proteins / Q000235:genetics*; D011506:Proteins / Q000235:genetics*; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics*; D057135:Wet Macular Degeneration / Q000188:drug therapy* / Q000235:genetics*
D061067:Antibodies, Monoclonal, Humanized; D050506:Mutant Chimeric Proteins; D011506:Proteins; D042461:Vascular Endothelial Growth Factor A